Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•
Home›Catalog›Antidiabetic Agents›Vildagliptin
Antidiabetic AgentsUSP / BP / EPRx Required (Finished Dosage) / Industrial API

Vildagliptin

Sub-Class: DPP-4 InhibitorsPrimary Therapeutic Use: DPP-4 Inhibitors - Therapeutic Sourcing Specification

🩺 Clinical Indications & Therapeutic Uses

Type 2 Diabetes treatment alone or in combination.

⚙️ How It Works (Mechanism of Action)

Clinical Administration & Action: Taken orally once or twice daily.. Acts on designated receptor and enzymatic pathways according to official pharmacopeial monograph standards to achieve systemic therapeutic efficacy.

🚫 Contraindications (When Not To Use)

Known hypersensitivity to Vildagliptin or related chemical analogs. Contraindicated in severe acute organ decompensation unless specifically managed under institutional clinical protocols.

⚠️ Precautions & Clinical Warnings

Perform liver function tests periodically.

International Strengths

Strictly USP / BP reference standards

50mg

Dosage Forms & Bulk API Grades

  • • Oral Tablets
  • • API Bulk Powder

Trade Bulk Vildagliptin

Supply active API raw materials or publish an official procurement tender.

🌐 International Pharmacopeia Reference Standards:

Generic specifications, molecular strengths, and indications in this catalog entry are compiled in alignment with international pharmacopeial reference standards including USP (United States Pharmacopeia), BP (British Pharmacopoeia), EP (European Pharmacopoeia), and the WHO Model List of Essential Medicines for wholesale B2B trade, regulatory dossier matching, and raw material procurement.

⚠️

Strict B2B Compliance & Non-Medical Prescription Notice:

This catalog entry is intended strictly for industrial B2B trade reference, dossier preparation, and wholesale sourcing among licensed pharmaceutical manufacturers, importers, and registered traders. It does not constitute consumer medical advice or individual prescription guidance.